News

Oil prices rose in Asian trade on Friday as traders placed a higher risk premium on crude oil amid growing concerns over Russia and Ukraine, capping a positive week. Supply disruptions in Norway and a brief drop in the dollar also supported oil prices early in the week, along with reports that the Organization of Petroleum Exporting Countries and allies (OPEC+) were likely to postpone planned production increases. The increased risk premium helped oil weather a bigger-than-expected rise in U.S. stockpiles. Brent oil futures for January expiration rose 0.4% to $74.54 a barrel, while West Texas Intermediate crude futures rose 0.5% to $70.10 a barrel by 20:44 ET (01:44 GMT). Both contracts were trading between 4% and 5% higher for the week. Russia-Ukraine tensions lead oil to wee...

The company's total income grew 36 percent to Rs 67,121.6 crore in FY24.iPhone maker Apple India has reported a 23 per cent rise in net profit to Rs 2,745.7 crore in FY2023-24.This information has been given in the company's regulatory filing shared by Tofler.Apple India had reported a net profit of Rs 2,229.6 crore in FY23. The company reported a 36 per cent rise in total income in FY24, rising to Rs 67,121.6 crore from Rs 49,321.8 crore in FY23.Toffler said, "Apple India Private Limited, which provides and markets Apple brand products and software, including mobile devices and laptops, reported revenue of Rs 67,122 crore for FY 2023-24, an increase of 36 per cent over the previous fiscal. The company's total expenses for the financial year (year) were reported at Rs 63,397 crore."

Shilpa Medicare shares rose over 6 per cent in early trade on November 19, after it announced that its subsidiary Shilpa Pharma Lifesciences has received two Certificates of Suitability (CEPs) from the European Directorate for Medicines and Healthcare Quality (EDQM).At 1.15 pm, Shilpa Medicare shares were trading over 3 per cent higher at Rs 892. The stock has rallied a massive 180 per cent on a year-to-date basis, outperforming the Nifty 50 by a huge margin, which gained 9 per cent during the same time period.The first CEP received on November 18 was for Octreotide The second CEP approval received on November 19 was for Nifedipine, an active pharmaceutical ingredient (API) classified as a calcium-channel blocker.Nifedipine is widely used for the management of hypertension and angina by r...

Shares of Crompton Greaves Consumer Electrical rose 7 per cent after the company reported a rise in its consolidated net profit and revenue for the quarter ended September. At 1.40 pm, Crompton Greaves shares were trading 4 per cent higher at Rs 385. The stock has gained 23 per cent on a year-to-date basis, outperforming the Nifty 50, which rose 8 per cent during the same time frame. The company reported a 27.8 per cent rise in consolidated net profit to Rs 124.9 crore, while revenue from operations rose 6.4 per cent to Rs 1,896 crore. Segment-wise, revenue from electric consumer durables (ECD) grew to Rs 1,392.7 crore from Rs 1,238 crore. Lighting products revenue also saw a marginal increase, rising to Rs 253 crore from Rs 238.7 crore. However, revenue from butterfly products d...

Narmada Agrobase Ltd has reported a manifold jump in net profit to Rs 1.29 crore in the July-September quarter on lower expenses. Revenue from operations for the second quarter of 2024-25 stood at Rs 10.24 crore as against Rs 11.40 crore in the previous year, the company said in a statement. Expenses declined to Rs 8.51 crore in the second quarter of FY25 from Rs 11.24 crore in the year-ago period. Operating profit or earnings before interest and tax depreciation amortisation increased to Rs 2.06 crore due to lower inventory and raw material costs. The company remains optimistic about its growth prospects in the next quarters with continued focus on key growth factors such as expansion into new markets, enhancing product offerings, the company said in a statement. The company ...

Shares of Jio Financial Services rose 7 to an intraday high of Rs 320.50 after NSE included the company in F&O contract.NSE released that futures and options contracts on 45 stocks, including Jio Financial Services, will start trading from November 29.In a indirect, NSE said, “ Members are advised to note that predicated on the stock selection criteria laid down by SEBI vide indirect no. SEBI/ HO/ MRD/ MRD- POD- 2/ P/ CIR/ 2024/116 dated August 30, 2024 and upon receipt of approbation from SEBI, members are hereby notified that futures and options contracts on the following 45 fresh securities will be available for trading from November 29, 2024. Jio Financial Services Q2 PerformanceThe company reported a 3 rise in its net profit for the alternate quarter of FY25 to Rs 668 crore as...

The HAL Q2 Results saw a marginal PBT growth close to 8 percent.On November 2030, Hindustan Aeronautics Limited published an announcement alleging a consolidated net profit of close to Rs 1510.49 crores that compounded year on year by 22.14%. It was lesser the PBT of Rs 1236.67 crores registered by the company in the July September quarter of the year beginning the fiscal year March 2024, the document mentions.Revenue for the second quarter reached Rs 5976.3 crores growing 7 percent from Rs 5635.4 crores for July- September quarters a year ago. There as a growth exhibited for earnings before interest and taxes in July quarter this year growing 7 out of the previous quarter earnings of Rs 1527.7 crores and ebitda grown up to 1604 crores. The shares also went up post earnings announcements ...

New Delhi, Nov 12 (PTI) Coal imports rose 2.2 percent to 111.20 million tonnes in the April-August period of the current fiscal as against 108.81 million tonnes in the same period a year ago, an official release said on Tuesday. However, the non-regulated sector witnessed a decline of 10.3 per cent during the April-August period as compared to the same period last year, the Coal Ministry said in the release. In value terms, the total imported coal during April-August 2024-25 was worth Rs 120,532.21 crore.  Despite a 4.97 percent increase in coal-based power generation from April to September 2024 over the same period last year, imports for blending purposes drop to 9.79 MT from 10.70 MT during the same period last year, showing decrease of 8.5 percent. "This decline underlines Ind...

Nov 12 (Reuters) - Indian drugmaker Zydus Lifesciences (ZYDU.NS), opens new tabon Tuesday reported a 14% rose in second-quarter profit, helped by strong demand for generic drugs in its key United States and Indian markets.The company's consolidated net profit rose to 9.11 billion rupees ($107.93 million), in line with analysts' average estimate of 9.13 billion rupees, according to data compiled by LSEG.Its total revenue rose 20% to 52.37 billion rupees, boosted by a nearly 30% rise in its U.S. market and a 10% inflation in its India business. These two markets contribute about 85% of Zydus Life's total revenue.For more on the earnings,.Key contextIndian generic drugmakers, which earn a large portion of their revenue from the U.S., have benefited from strong demand for their copycat versio...